Imaging brain tumors by targeting peptide radiopharmaceuticals through the blood-brain barrier

Cancer Research

Volumn 59, Issue 24, 1999, Pages 6159-6163

  Kurihara, Atsushi ^a   Pardridge, William M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; INDIUM 111; MONOCLONAL ANTIBODY; PEPTIDE; RADIOPHARMACEUTICAL AGENT; TRANSFERRIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TUMOR; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TARGETING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; STEREOSPECIFICITY; TRANSCYTOSIS; TUMOR GROWTH;

ANIMALS; BIOTINYLATION; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; EPIDERMAL GROWTH FACTOR; HUMANS; INDIUM RADIOISOTOPES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PENTETIC ACID; PEPTIDES; RADIOPHARMACEUTICALS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR CELLS, CULTURED;

EID: 0033572574     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Black, P. M. Brain tumors, N. Engl. J. Med., 324: 1471-1476, 1991.
2. Zhang, R., Price, J. E., Fujimaki, T., Bucana, C. D., and Fidler, I. J. Differential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice. Am. J. Pathol., 141: 1115-1124, 1992.
3. Gruber, M. L., and Hochberg, F. H. Systematic evaluation of primary brain tumors. J. Nucl. Med., 31: 969-971, 1990.
4. Levin, V. A., Freeman-Dove, M., and Landahl, H. D. Permeability characteristics of brain adjacent to tumors in rats. Arch. Neurol., 32: 785-791, 1975.
5. Libermann, T. A., Nusbaum, H. R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittles, N., Waterfield, M. D., Ullrich, A., and Schlessinger. J. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature (Lond.), 313: 144-147, 1985.
6. Wong, A. J., Bigner, S. H., Bigner, D. D., Kinzler, K. W., Hamilton, S. R., and Vogelstein, B. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc. Natl. Acad. Sci. USA, 84: 6899-6903, 1987.
7. 99Tc and in vivo localization following intracerebral injection into normal and glioma-bearing rats. Bioconjugate Chem., 8: 289-295, 1997.
8. Nave, K. A., Probstmeier, R., and Schachner, M. Epidermal growth factor does not cross the blood-brain barrier. Cell Tissue Res., 241, 453-457, 1985.
9. Kalofonos, H. P., Pawlikowska, T. R., Hemingway, A., Courtenay-Luck, N., Dhokia, B., Snook, D., Sivolapenko, G. B., Hooker, G. B., McKenzie, C. G., Lavender, P. J., Thomas, D. G., and Epenetos, E. E. Antibody guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal growth factor receptor and placental alkaline phosphatase. J. Nucl. Med., 30: 1636-1645, 1989.
10. Pardridge, W. M. Peptide Drug Delivery to the Brain, pp. 1-357, New York: Raven, 1991.
11. Torp, S. H., Helseth, E., Dalen, A., and Unsgaard, G. Epidermal growth factor receptor expression in human gliomas. Cancer Immunol. Immunother., 33: 61-64, 1991.
12. 111ln]-chelation, conjugation to a blood-brain barrier delivery vector via a biotin-polyethyleneglycol linker, pharmacokinetics, and in imaging imaging of experimental brain tumors. Bioconjugate Chem., 10: 502-511, 1999.
13. Bickel, U., Kang, Y-S., Yoshikawa, T., and Pardridge, W. M. In vivo demonstration of suncellular localization of anti-transferrin receptor monoclonal antibody-colloidal gold conjugate within brain capillary endotheliuin. J. Histochem. Cytochem., 42: 1493-1497, 1994.
14. 125l]transferrin through the rat blood-brain barrier in vivo. Brain Res., 164: 164-171, 1995.
15. Deguchi, Y., Kurihara, A., and Pardridge, W. M. Retention of biologic activity of human epidermal growth factor following conjugation to a blood-brain barrier drug delivery vector via extended polyethyleneglycol linker. Bioconjugate Chem., 10: 32-37, 1999.
16. Wu, D., and Pardridge, W. M. Central nervous system pharmacologic effect in conscious rats after intravenous injection of a biotinylated vasoactive intestinal peptide analog coupled to a blood-brain barrier drug delivery system. J. Pharmacol. Exp. Ther., 279: 77-83, 1996.
17. Huang, H. J., Nagane, M., Klingbeil, C. K., Lin, H., Nishikawa, R., Ji, X. D., Huang, C. M., Gill, G. N., Wiley, H. S., and Cavenee, W. K. The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. J. Biol. Chem., 272: 2927-2935, 1997.
18. Fenstermaker, R. A., Capala, J., Barth, R. F., Hujer, A., Kung, H-J., and Kaetzel, D. M. The effect of epidermal growth factor receptor (EGFR) expression on in vivo growth of rat C6 glioma cells. Leukemia (Baltimore), 9: S106-S112, 1995.
19. Chopp, M., Madigan, L., Dereski, M., Jiang, F., and Li, Y. Photodynamic therapy of human glioma (U87) in the nude rat. Photochem. Photobiol., 64: 707-711, 1996.
20. Yuan, F., Salehi, H. A., Boucher, Y., Vasthare, U. S., Tuma, R. F., and Jain, R. K. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res., 54: 4564-4568, 1994.
21. French, A. R., Tadaki, D. K., Niyogi, S. K., and Lauffenburger, D. A. Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor/ligand interaction. J. Biol. Chem., 270: 4334-4340, 1995.
22. Bender, H., Emrich, J. G., Eshelman, J., Chu, M. A., Steplewski, Z., Biersack, H. J., and Brady, L. W. Enhancement of monoclonal antibody efficacy: the effect of external beam radiation. Hybridoma. 14: 129-134, 1995.
23. Dadaparvar, S., Krishna, L., Miyamoto, C., Brady, L. W., Brown, S. J., Bender, H., Slizofski, W. J., Eshleman, J., Chevres, A., and Woo, D. V. Indium-111-labeled anti-EGFR-425 scintigraphy in the detection of malignant gliomas. Cancer (Phila.), 73(Suppl. 3): 884-889, 1994.
24. Pardridge, W. M., Kang, Y-S., Buciak, J. L., and Yang, J. Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate. Pharm. Res., 12: 807-816, 1995.
25. Wu, D., Yang, J., and Pardridge, W. M. Drug targeting of a peptide radiopharmaceutical through the primate blood-brain harrier in with with a monoclonal antibody to the human insulin receptor. J. Clin. Investig., 100: 1804-1812, 1997.
26. Blanco-Aparicio, C., Molina, M. A., Fernandez,-Salas, E., Frazier, M. L., Mas, J. M., Querol, E., Aviles, F. X., and de Llorens, R. Potato carboxypeptidase inhibitor, a T-knot protein, is an epidermal growth factor antagonist that inhibits tumor cell growth. J. Biol. Chem., 273: 12370-12377, 1998.
27. Pardridge, W. M. Vector-mediated drug delivery to the brain. Adv. Drug Delivery Rev., 36: 299-321, 1999.